Research suggests Ozempic could reduce Alzheimer's risk in type 2 diabetes, with a 67% lower diagnosis rate compared to ...

Ozempic and other GLP-1 drugs show promise not only in managing obesity and diabetes but also in reducing Alzheimer's risk. A ...

The University of Cincinnati's Alberto Espay, MD, commented to NBC News on new research published Oct. 24 that found ...

Ozempic has quickly become a household name with medical researchers claiming the breakthrough drug can have many benefits.

As the popularity of GLP-1 meds like Wegovy and Zepbound grows, fewer Americans are turning to weight-loss surgeries to trim ...

Semaglutide, the active ingredient in Ozempic and Wegovy, may lower the risk of Alzheimer’s disease.A new study suggests type 2 diabetes patients taking semaglu ...

A new study reveals that the active ingredient in drugs like Ozempic and Wegovy could lower the risk of developing ...

Researchers at the Case Western Reserve School of Medicine have found that semaglutide, a popular diabetes and weight-loss ...

A new study shows otherwise healthy adults who take broad-spectrum antibiotics to treat community-acquired pneumonia are more likely to suffer adverse drug events. Also in the news: evolution of covid ...

Sanofi and CD&R entered into exclusive negotiations for the potential sale and purchase of a 50% controlling stake in Opella.

Semaglutide, the blood sugar control and weight loss drug, has another added benefit. A recent study, published in ...

Could Ozempic lower one’s risk of Alzheimer’s disease? One study says it may. NewsNation medical contributor Dr. Dave Montgomery joins “Morning in America” to discuss the research. #Ozempic #Alzheimer ...